Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunose FLU in healthy adults
NCT02998996Phase 2Completed
- Sponsor
- Eurocine Vaccines AB
- Start
- Sep 2016
- Primary completion
- Jun 2017
- Modality
- Prophylactic Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Immunose FLU in influenza (6 arms), sponsored by Eurocine Vaccines AB. Primary endpoints: Local Tolerability - First Dose and Local Tolerability - Second Dose. Started Sep 2016; status: completed.
02
Drugs
Immunose FLU
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02998996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02998996.